{"id":"https://openalex.org/W4388080287","doi":"https://doi.org/10.1182/bloodadvances.2023010966","title":"Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide\u2013based transplant","display_name":"Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide\u2013based transplant","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388080287","doi":"https://doi.org/10.1182/bloodadvances.2023010966","pmid":"https://pubmed.ncbi.nlm.nih.gov/37906513","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10698256"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2023010966","doi":"https://doi.org/10.1182/bloodadvances.2023010966","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010966","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/7/23/7153/2176253/blooda_adv-2023-010966-main.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/7/23/7153/2176253/blooda_adv-2023-010966-main.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055514880","display_name":"Andrew P. Lin","orcid":"https://orcid.org/0000-0002-7446-142X","observed_orcids":["https://orcid.org/0000-0002-7446-142X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Lin","raw_affiliation_strings":["1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":"https://orcid.org/0000-0002-7446-142X","affiliations":[{"raw_affiliation_string":"1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012777769","display_name":"Samantha Brown","orcid":"https://orcid.org/0000-0001-5352-974X","observed_orcids":["https://orcid.org/0000-0001-5352-974X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha Brown","raw_affiliation_strings":["2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":"https://orcid.org/0000-0001-5352-974X","affiliations":[{"raw_affiliation_string":"2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011056604","display_name":"Stephanie Chinapen","orcid":"https://orcid.org/0000-0001-6308-9346","observed_orcids":["https://orcid.org/0000-0001-6308-9346"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Chinapen","raw_affiliation_strings":["1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":"https://orcid.org/0000-0001-6308-9346","affiliations":[{"raw_affiliation_string":"1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100661990","display_name":"Yeon Joo Lee","orcid":"https://orcid.org/0000-0002-2997-0217","observed_orcids":["https://orcid.org/0000-0002-2997-0217"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yeon Joo Lee","raw_affiliation_strings":["3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000249065","display_name":"Susan K. Seo","orcid":"https://orcid.org/0000-0002-3370-4691","observed_orcids":["https://orcid.org/0000-0002-3370-4691"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan K. Seo","raw_affiliation_strings":["3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066163702","display_name":"Doris M. Ponce","orcid":"https://orcid.org/0000-0002-9422-5766","observed_orcids":["https://orcid.org/0000-0002-9422-5766"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doris M. Ponce","raw_affiliation_strings":["1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":"https://orcid.org/0000-0002-9422-5766","affiliations":[{"raw_affiliation_string":"1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043680453","display_name":"Zainab Shahid","orcid":"https://orcid.org/0000-0002-6664-8243","observed_orcids":["https://orcid.org/0000-0002-6664-8243"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zainab Shahid","raw_affiliation_strings":["3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070096873","display_name":"Sergio Giralt","orcid":"https://orcid.org/0000-0003-1944-5053","observed_orcids":["https://orcid.org/0000-0003-1944-5053"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergio Giralt","raw_affiliation_strings":["1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":"https://orcid.org/0000-0003-1944-5053","affiliations":[{"raw_affiliation_string":"1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079087824","display_name":"Genovefa A. Papanicolaou","orcid":"https://orcid.org/0000-0002-2891-079X","observed_orcids":["https://orcid.org/0000-0002-2891-079X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Genovefa A. Papanicolaou","raw_affiliation_strings":["3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Infectious Diseases Service, Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082333371","display_name":"Miguel\u2010Angel Perales","orcid":"https://orcid.org/0000-0002-5910-4571","observed_orcids":["https://orcid.org/0000-0002-5910-4571"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miguel-Angel Perales","raw_affiliation_strings":["1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":"https://orcid.org/0000-0002-5910-4571","affiliations":[{"raw_affiliation_string":"1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064076262","display_name":"Brian C. Shaffer","orcid":"https://orcid.org/0000-0003-3433-9179","observed_orcids":["https://orcid.org/0000-0003-3433-9179"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brian C. Shaffer","raw_affiliation_strings":["1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","4Department of Internal Medicine, Weill Cornell Medical School, New York, NY"],"raw_orcid":"https://orcid.org/0000-0003-3433-9179","affiliations":[{"raw_affiliation_string":"1Adult BMT Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Department of Internal Medicine, Weill Cornell Medical School, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064076262"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4387153466"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":3.1094,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.92608735,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"7","issue":"23","first_page":"7153","last_page":"7160"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytomegalovirus-reactivation","display_name":"cytomegalovirus reactivation","score":0.9110000133514404},{"id":"https://openalex.org/keywords/letermovir","display_name":"letermovir","score":0.9010000228881836},{"id":"https://openalex.org/keywords/post-transplant-cyclophosphamide","display_name":"post-transplant cyclophosphamide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9850000143051147},{"id":"https://openalex.org/keywords/graft-versus-host-disease-prophylaxis","display_name":"graft-versus-host disease prophylaxis","score":0.902999997138977},{"id":"https://openalex.org/keywords/hypogammaglobulinemia","display_name":"hypogammaglobulinemia","score":0.9129999876022339},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9589999914169312},{"id":"https://openalex.org/keywords/t-cell-reconstitution","display_name":"T cell reconstitution","score":0.9200000166893005},{"id":"https://openalex.org/keywords/b-cell-reconstitution","display_name":"B cell reconstitution","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cmv-end-organ-disease","display_name":"CMV end-organ disease","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7190735340118408},{"id":"https://openalex.org/C2777805810","wikidata":"https://www.wikidata.org/wiki/Q1047559","display_name":"Hypogammaglobulinemia","level":3,"score":0.7029116153717041},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5695984959602356},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5372436046600342},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5174922943115234},{"id":"https://openalex.org/C2777732132","wikidata":"https://www.wikidata.org/wiki/Q6946","display_name":"Cytomegalovirus","level":5,"score":0.49973368644714355},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.49797701835632324},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49682357907295227},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4812335968017578},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.474484920501709},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.4538518190383911},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4288962483406067},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4278600811958313},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42497238516807556},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.39425721764564514},{"id":"https://openalex.org/C2776409557","wikidata":"https://www.wikidata.org/wiki/Q149348","display_name":"Herpesviridae","level":4,"score":0.2568456530570984},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1578163206577301},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14645510911941528},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.13136440515518188},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1102069616317749},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000361","descriptor_name":"Agammaglobulinemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003587","descriptor_name":"Cytomegalovirus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2023010966","doi":"https://doi.org/10.1182/bloodadvances.2023010966","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010966","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/7/23/7153/2176253/blooda_adv-2023-010966-main.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10698256","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10698256","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10698256/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:37906513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37906513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2023010966","doi":"https://doi.org/10.1182/bloodadvances.2023010966","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010966","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/7/23/7153/2176253/blooda_adv-2023-010966-main.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G1574533925","display_name":"Immunobiology of Allogeneic Hematopoietic Cell Transplantation","funder_award_id":"P01CA023766","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2207172873","display_name":"Optimizing NK Education and Alloreactivity after HLA-Haploidentical Allogeneic Hematopoietic Cell Transplantation","funder_award_id":"K23HL140134","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000174336","display_name":null,"funder_award_id":"CA 008748","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320312132","display_name":"Actinium Pharmaceuticals","ror":"https://ror.org/04zamhr10"},{"id":"https://openalex.org/F4320312222","display_name":"Cidara Therapeutics","ror":"https://ror.org/044pnsw08"},{"id":"https://openalex.org/F4320312570","display_name":"Jazz Pharmaceuticals","ror":"https://ror.org/055mhsv54"},{"id":"https://openalex.org/F4320316633","display_name":"CareDx","ror":"https://ror.org/035bmh889"},{"id":"https://openalex.org/F4320317395","display_name":"Amplyx","ror":"https://ror.org/02jfsdq79"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320319050","display_name":"Omeros Corporation","ror":"https://ror.org/01r5k6556"},{"id":"https://openalex.org/F4320328062","display_name":"MorphoSys","ror":"https://ror.org/00ew7rg06"},{"id":"https://openalex.org/F4320330792","display_name":"EUSA Pharma","ror":"https://ror.org/01p7jrr32"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320333647","display_name":"Kite Pharma","ror":"https://ror.org/05waa9105"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388080287.pdf","grobid_xml":"https://content.openalex.org/works/W4388080287.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1719485448","https://openalex.org/W1783822653","https://openalex.org/W2050830700","https://openalex.org/W2116483603","https://openalex.org/W2149481157","https://openalex.org/W2152041770","https://openalex.org/W2157191688","https://openalex.org/W2395266396","https://openalex.org/W2771598353","https://openalex.org/W2936711845","https://openalex.org/W3012802544","https://openalex.org/W3092010118","https://openalex.org/W3095258418","https://openalex.org/W3134682479","https://openalex.org/W3135137897","https://openalex.org/W3156749144","https://openalex.org/W3194043411","https://openalex.org/W3196207405","https://openalex.org/W3198243526","https://openalex.org/W3213596607","https://openalex.org/W4206414146","https://openalex.org/W4280641854","https://openalex.org/W4307425817","https://openalex.org/W4312223834","https://openalex.org/W6847929831"],"related_works":["https://openalex.org/W4405318121","https://openalex.org/W3168160989","https://openalex.org/W4412479369","https://openalex.org/W3156882885","https://openalex.org/W4386476150","https://openalex.org/W3014808921","https://openalex.org/W3213596607","https://openalex.org/W4391598171","https://openalex.org/W4411763887","https://openalex.org/W4310113856"],"abstract_inverted_index":{"Reactivation":[0],"of":[1,9,36,67,75,93,111,123,133,156,160,196],"latent":[2],"cytomegalovirus":[3],"(CMV)":[4],"is":[5,230],"increased":[6],"in":[7,42,64,169,191,211,225],"recipients":[8,66,182],"allogeneic":[10],"hematopoietic":[11],"cell":[12],"transplantation":[13],"(allo-HCT)":[14],"with":[15,73,183,193,214,227],"seropositive":[16,184],"CMV":[17,39,124,194],"using":[18],"posttransplant":[19],"cyclophosphamide":[20],"(PT-Cy)-based":[21],"graft-versus-host":[22],"disease":[23],"(GVHD)":[24],"prophylaxis.":[25],"Letermovir,":[26],"a":[27,231],"novel":[28],"DNA":[29],"terminase":[30],"complex":[31],"inhibitor,":[32],"reduces":[33],"the":[34,90,107],"incidence":[35,110],"clinically":[37],"significant":[38],"infection":[40],"(csCMVi)":[41],"this":[43,88],"population;":[44],"however,":[45],"parameters":[46,63],"that":[47,204],"predict":[48],"csCMVi":[49,82,112,134,173,205,236],"after":[50,206,237],"letermovir":[51,79,94,105,129,151,167,197,207,238],"withdrawal":[52,152,168,208],"are":[53],"not":[54,154],"well":[55],"described.":[56],"Here,":[57],"we":[58],"examined":[59],"clinical":[60],"and":[61,83,147],"immunological":[62],"294":[65],"PT-Cy-based":[68],"allo-HCT,":[69],"including":[70],"157":[71],"patients":[72,170,192,212,226],"CMV,":[74,185],"whom":[76],"80":[77],"completed":[78],"prophylaxis":[80],"without":[81],"subsequently":[84],"stopped":[85],"letermovir.":[86],"In":[87,181],"population,":[89],"median":[91],"duration":[92],"exposure":[95],"was":[96,113,131,189,209],"203":[97],"days":[98],"(interquartile":[99],"range":[100],"[IQR],":[101],"160-250":[102],"days).":[103],"After":[104],"withdrawal,":[106],"90-day":[108],"cumulative":[109],"23.0%":[114],"(95%":[115],"confidence":[116,139],"interval,":[117,140],"14.3-32.8).":[118],"There":[119],"were":[120,153,164],"no":[121],"episodes":[122],"end-organ":[125],"disease.":[126],"Hypogammaglobulinemia":[127],"before":[128,150,166],"discontinuation":[130],"predictive":[132,155],"(hazard":[135],"ratio,":[136],"0.33;":[137],"95%":[138],"0.12-0.93;":[141],"P":[142,178],"=":[143,179],".03),":[144],"whereas":[145],"T-cell":[146,187],"B-cell":[148],"reconstitution":[149,188],"csCMVi.":[157],"Higher":[158],"numbers":[159],"natural":[161],"killer":[162],"cells":[163],"found":[165],"who":[171],"experienced":[172],"(median,":[174],"202":[175],"vs":[176],"160;":[177],".03).":[180],"CD3+CD4-CD8+":[186],"faster":[190],"regardless":[195],"exposure.":[198,218],"Taken":[199],"together,":[200],"these":[201],"data":[202],"suggest":[203],"frequent":[210],"treated":[213],"PT-Cy,":[215],"despite":[216],"prolonged":[217],"Strategies":[219],"to":[220,234],"boost":[221],"CMV-specific":[222],"adaptive":[223],"immunity":[224],"persistent":[228],"hypogammaglobulinemia":[229],"logical":[232],"pathway":[233],"reduce":[235],"withdrawal.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-11-01T00:00:00"}